Nanalysis Scientific Corp. (NSCI.V)
| Previous close | 0.4450 |
| Open | 0.4500 |
| Bid | 0.4250 x N/A |
| Ask | 0.4400 x N/A |
| Day's range | 0.4250 - 0.4500 |
| 52-week range | 0.3450 - 0.6600 |
| Volume | |
| Avg. volume | 84,487 |
| Market cap | 49.167M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1600 |
| Earnings date | 22 Aug 2024 - 29 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.20 |
PR NewswireNanalysis Announces First Quarter 2024 Results
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces first quarter results for the period ending on March 31, 2024, achieving 139% year-over-year revenue growth to $11.2 million in Q1. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will b
PR NewswireNanalysis Announces First Quarter 2024 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Wednesday, May 29th, 2024, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending March 31, 2024.
Simply Wall St.Nanalysis Scientific Full Year 2023 Earnings: CA$0.16 loss per share (vs CA$0.098 loss in FY 2022)
Nanalysis Scientific ( CVE:NSCI ) Full Year 2023 Results Key Financial Results Revenue: CA$28.5m (up 15% from FY 2022...
